Top 10 Neurology Articles of 2016: NEJM Journal Watch Editors’ Picks
Information sourced from NEJM Journal Watch:
NEJM Journal Watch Neurology Top Stories of 2016
S. Andrew Josephson, MD
A perspective on the most important research in the field from the past year
I am pleased to introduce this year’s NEJM Journal Watch Neurology Top Stories of 2016. As in years past, I have made these selections after carefully reviewing all of the year’s summaries. In making the choices, I have tried to strike a balance between relevance to the clinician, coverage of the various fields within neurology, recognition of landmark studies, and media publicity and public awareness. The sequence of stories is not intended to reflect their relative importance. I hope you find the list useful and thought-provoking.
The NEJM Journal Watch Neurology Top Stories of 2016, in no particular order, are:
Surgical Decompression for Degenerative Cervical Myelopathy
Meta-Analysis Supports Benefit of Endovascular Stroke Therapy
Does Stopping Donepezil for Alzheimer Disease Increase Nursing Home Placement?
Cerebral Cavernous Malformations: Which Ones Should We Worry About?
Phase 2 Trial of Rivastigmine for Fall Prevention in Parkinson Patients
Ten-Year Stroke Risk Is Comparable After Carotid Stenting or Endarterectomy
Treatment of Convulsive Status Epilepticus: Evidence-Based Guidelines
What Is the Relapse Risk in Acute Disseminated Encephalomyelitis?
Thymectomy for Myasthenia Gravis
Calcium Supplements Linked to Dementia Risk in Women with Cerebrovascular Disease
Best wishes for a happy and productive 2017.
NEJM Journal Watch is produced by NEJM Group, a division of the Massachusetts Medical Society. Copyright ©2017 Massachusetts Medical Society. All rights reserved.
The above message comes from NEJM Journal Watch, who is solely responsible for its content.
You have received this email because you requested follow-up information to an Epocrates DocAlert® message. For more information about Epocrates, please click here.
For questions, feedback, or suggestions regarding Epocrates DocAlert® messages, please contact the Medical Information Team at email@example.com.